CLRB (CLRB) Stock Price & Analysis
CLRB (CLRB) rose 0.85% to USD 2.37 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.
CLRB last closed at USD 2.37; the session ranged USD 2.35–2.4 on volume of 26,575 shares. Market capitalization is —, with a 52-week range of USD 2.2–6.52 (NCM). Source: Nexqual, September 8, 2026 at 07:36 UTC.
Key Statistics (as of September 8, 2026 at 07:36 UTC)
| Price | USD 2.37 |
|---|---|
| Change | ▲ 0.85% (up) |
| Previous Close | USD 2.37 |
| Open | USD 2.37 |
| Day Range | USD 2.35 – 2.4 |
| 52-Week Range | USD 2.2 – 6.52 |
| Volume | 26,575 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CLRB)
Nexqual's technical model rates CLRB "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.98 (neutral) |
| vs SMA50 | Below (USD 2.57) |
| MACD | -0.04 (negative) |
Earnings (CLRB)
| Next Earnings Date | 2026-11-12 |
|---|---|
| EPS Estimate | USD -0.56 |
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.57 vs est -0.52 ▼ miss |
| 2026-03-31 | USD -1.33 vs est -1.89 ▲ beat |
| 2025-12-31 | USD -0.53 vs est -1.23 ▲ beat |
| 2025-09-30 | USD -1.41 vs est -2.53 ▲ beat |
Source: Nexqual, September 8, 2026 at 07:36 UTC.
Financials & Fundamentals (CLRB)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -119.57% |
| Debt / Equity | 5.13 |
| Current Ratio | 6.66 |
| Total Cash | $33.99M |
| Total Debt | $1.53M |
| Free Cash Flow | $-12.52M |
Source: Nexqual, September 8, 2026 at 07:36 UTC.
Ownership (CLRB)
| Insider Ownership | +1.75% |
|---|---|
| Institutional Ownership | +34.71% |
| Shares Outstanding | 9.45M |
| Float | 9.28M |
| Short % of Float | +1.71% |
Source: Nexqual, September 8, 2026 at 07:36 UTC.
From CLRB's Latest SEC 10-K Filing (filed 2026-03-04)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PULM | Pulmatrix, Inc. | USD 1.39 | ▼ 5.44% |
| MBRX | Moleculin Biotech, Inc. | USD 0.71 | ▲ 2.29% |
| BLRX | BioLineRx Ltd. | USD 2.67 | ▼ 2.55% |
| CBIO | Crescent Biopharma, Inc. | USD 20.88 | ▲ 12.62% |
| HEPA | Hepion Pharmaceuticals, Inc. | USD 0.09 | ▲ 23.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.